Martinez-Recio, S.; Molina-Pérez, M.A.; Muñoz-Couselo, E.; Sevillano-Tripero, A.R.; Aya, F.; Arance, A.; Orrillo, M.; Martin-Liberal, J.; Fernandez-Morales, L.; Lesta, R.;
et al. Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse. Cancers 2025, 17, 143.
https://doi.org/10.3390/cancers17010143
AMA Style
Martinez-Recio S, Molina-Pérez MA, Muñoz-Couselo E, Sevillano-Tripero AR, Aya F, Arance A, Orrillo M, Martin-Liberal J, Fernandez-Morales L, Lesta R,
et al. Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse. Cancers. 2025; 17(1):143.
https://doi.org/10.3390/cancers17010143
Chicago/Turabian Style
Martinez-Recio, Sergio, Maria Alejandra Molina-Pérez, Eva Muñoz-Couselo, Alberto R. Sevillano-Tripero, Francisco Aya, Ana Arance, Mayra Orrillo, Juan Martin-Liberal, Luis Fernandez-Morales, Rocio Lesta,
and et al. 2025. "Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse" Cancers 17, no. 1: 143.
https://doi.org/10.3390/cancers17010143
APA Style
Martinez-Recio, S., Molina-Pérez, M. A., Muñoz-Couselo, E., Sevillano-Tripero, A. R., Aya, F., Arance, A., Orrillo, M., Martin-Liberal, J., Fernandez-Morales, L., Lesta, R., Quindós-Varela, M., Nieva, M., Vidal, J., Martinez-Perez, D., Barba, A., & Majem, M.
(2025). Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse. Cancers, 17(1), 143.
https://doi.org/10.3390/cancers17010143
